A major international study has found that patients with systemic sclerosis (SSc) face a significantly higher risk of ...

The FDA has approved Tezspire (tezepelumab-ekko), a biologic therapy by Amgen and AstraZeneca, as an add-on maintenance ...

While colorectal cancer polyps often have no symptoms—especially in the early stages—there are some warning signs to be on ...

Approval based on WAYPOINT Phase III results demonstrating reduced nasal polyp severity and nasal congestion, near-elimination of the need for surgery and significantly reduced systematic ...

AstraZeneca and Amgen's Tezspire (tezepelumab) has been approved in the European Union (EU) as an add-on therapy with ...

Some experts worry about the risk of overdiagnosis of benign conditions and the lack of research showing AI technology ...

Investing.com -- AstraZeneca and Amgen have received European Union approval for Tezspire as an add-on therapy for adults ...

Abstract: Automated segmentation of gastrointestinal polyps is a critical step in the early detection and prevention of colorectal cancer (CRC), which is one of the most common causes of ...

Uterine fibroids are common growths that cause confusion and fear. Many women believe they are cancerous or always need ...

Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Plaintiff counsel with Cash, Krugler & Fredericks credit the seven-figure outcome to their ability to convey to jurors an ...